4
Changes in Ownership
Amneal Pharmaceuticals, Inc. Filed Acc 0001628280-25-010693
President & Co-CEO gave up 326,888 shares (to pay taxes)
- President & Co-CEO acquired 672,302 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patel Chirag K. President & Co-CEO | 2025-03-03 | Option exercise | +579,710 | 1,092,276 | D | ||
| Patel Chirag K. President & Co-CEO | 2025-03-03 | Shares withheld for taxes | −279,527 | $8.76 | $2,448,657 | 812,749 | D |
| Patel Chirag K. President & Co-CEO | 2025-03-04 | Option exercise | +92,592 | 905,341 | D | ||
| Patel Chirag K. President & Co-CEO | 2025-03-04 | Shares withheld for taxes | −47,361 | $8.84 | $418,671 | 857,980 | D |
| Derivatives | |||||||
| Patel Chirag K. President & Co-CEO | 2025-03-03 | Option exercise · Performance-Based Restricted Stock Units | −579,710 | 0 | D | ||
| Patel Chirag K. President & Co-CEO | 2025-03-03 | Grant or award · Performance-Based Restricted Stock Units | +890,410 | 890,410 | D | ||
| Patel Chirag K. President & Co-CEO | 2025-03-03 | Grant or award · Restricted Stock Units | +239,726 | 239,726 | D | ||
| Patel Chirag K. President & Co-CEO | 2025-03-04 | Option exercise · Restricted Stock Units | −92,592 | 277,778 | D | ||
Loading xslF345X05/wk-form4_1741221213.xml…